name,gyr_cdrs_Rg_std_350,bonds_contacts_std_350,rmsf_cdrl1_std_350,tm
DAB006808_daclizumab,0.0,14.7,0.1,69.8
DAB006768_sirukumab,0.0,14.2,0.1,67.9
DAB005027_epratuzumab,0.0,14.1,0.1,64.3
DAB005017,0.0,14.2,0.1,74.3
DAB006826,0.0,15.5,0.1,54.1
DAB006766_sifalimumab,0.0,14.0,0.1,65.9
